Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • ASNR Foundation Special Collection
    • Most Impactful AJNR Articles
    • Photon-Counting CT
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR is seeking candidates for the AJNR Podcast Editor. Read the position description.

Research ArticlePediatrics
Open Access

White Matter Characteristics and Cognition in Prenatally Opiate- and Polysubstance-Exposed Children: A Diffusion Tensor Imaging Study

K.B. Walhovd, L.T. Westlye, V. Moe, K. Slinning, P. Due-Tønnessen, A. Bjørnerud, A. van der Kouwe, A.M. Dale and A.M. Fjell
American Journal of Neuroradiology May 2010, 31 (5) 894-900; DOI: https://doi.org/10.3174/ajnr.A1957
K.B. Walhovd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L.T. Westlye
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Moe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Slinning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Due-Tønnessen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Bjørnerud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. van der Kouwe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M. Dale
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A.M. Fjell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

BACKGROUND AND PURPOSE: Prenatal drug exposure may influence the developing brain. Our aim was to study WM characteristics with DTI in children with prenatal opiate and polysubstance exposure and in controls. We assessed whether group differences in FA, DA, and DR could be found and related to cognitive function.

MATERIALS AND METHODS: The study was approved by a committee for medical research ethics. Parents signed an informed consent; children gave spoken consent. Our sample included 14 prenatally substance-exposed adopted children (5 girls; age range, 8.6–13.9 years; mean, 11.3 ± 1.7 years) and 14 control children (7 girls; age range, 9.0–10.2 years; mean, 9.8 ± 0.3 years). Tract-based spatial statistics were used to define a common WM skeleton for the sample, and FA was compared between groups throughout the skeleton, controlling for age and sex. Clusters of significant group differences ≥100 voxels (P <. 05) were identified. FA, DA, and DR within clusters were correlated with cognitive function.

RESULTS: Ten clusters of FA group differences, mostly in central, posterior, and inferior parts of the brain, were identified (P <. 05), showing lower FA in substance-exposed children. FA and DA correlated positively and DR, negatively with cognitive function across groups.

CONCLUSIONS: Prenatally substance-exposed children exhibited lower FA in restricted areas of WM, mostly relatively central, inferior, and posterior, where myelination occurs early in development. Myelin in these areas may be particularly vulnerable to prenatal substance exposure. FA and DR related moderately to cognitive function. Potential confounding factors existed and were considered.

Abbreviations

ADHD
attention deficit/hyperactivity disorder
ANOVA
analysis of variance
AS
Asperger syndrome
ATRL
anterior thalamic radiation, left
ATRR
anterior thalamic radiation, right
CC
corpus callosum
CGL
cingulum gyrus, left
CGR
cingulum gyrus, right
CHL
cingulum hippocampal part, left
CHR
cingulum hippocampal part, right
CNS
central nervous system
CSTL
corticospinal tract, left
CSTR
corticospinal tract, right
DA
axial diffusion
DR
radial diffusion
DTI
diffusion tensor imaging
FA
fractional anisotropy
FASD
fetal alcohol spectrum disorders
FFD
freedom from distractibility
Fmaj
forceps major
Fmin
forceps minor
FMRIB
Functional MRI of the Brain
GCI
general cognitive index
GLM
general linear model
ILF
inferior longitudinal fasciculus
ILFL
inferior longitudinal fasciculus, left
ILFR
inferior longitudinal fasciculus, right
IQ
intelligence quotient
L
left
PPS
Perceptual Performance Scale
R
right
SES
socioeconomic status
SLF
superior longitudinal fasciculus
SLFL
superior longitudinal fasciculus, left
SLFR
superior longitudinal fasciculus, right
UF
uncinate fasciculus
UFL
uncinate fasciculus, left
UFR
uncinate fasciculus, right
WISC-R
Wechsler Intelligence Scale for Children-Revised
WM
white matter

Drugs of abuse can potentially affect mitosis, migration, and survival of cells in the developing CNS. Children born to substance-abusing women have increased risk of regulatory and neuropsychological difficulties,1–4 and neuroanatomic volumetric differences between exposed children and controls have been documented for alcohol,5 methamphetamine, and heroin.6–8 In the formation of the human CNS, neurons arise first, followed by astrocytes, and then oligodendrocytes.9 The latter form myelin, the insulating layer around axons, which enables speedy and synchronized transmission of nerve signals. Brain myelination begins relatively late, mostly after midgestation, develops rapidly in infancy, and continues at a slower pace well into adulthood.9 However, much of the foundation of myelination is cast in utero, so one should examine potentially relevant factors at this stage.

Little is known about the effects of different drugs on developing WM, but WM abnormalities, particularly in the posterior CC, have been well documented by structural MR imaging in FASD.5,10 It has also been reported that children born to mothers with opiate and polysubstance abuse have smaller neuroanatomic volumes, including WM volume.8 This finding may be linked to studies showing opiate-induced apoptosis in neurons and microglia.11 Less is known about mechanisms by which opiates and other drugs regulate oligodendrocytes, but these cells also express specific opiate receptors and can respond to changes in the level of stimulation.12 Opioid receptor activation can regulate cellular development, so one could speculate that chronic opiate exposure might cause lasting changes in neural function by disrupting gliogenesis.13

DTI provides a measure of microstructural WM characteristics by using the restricted water diffusion in biologic brain tissues. FA is an intravoxel index of the degree of diffusion anisotropy. Several features contribute to FA, including degree of myelination and axonal integrity.14,15 FA consists of components measured DA and DR to the principal diffusion direction. Three DTI studies of WM characteristics in FASD have been conducted, and all reported effects in the posterior CC.10,16,17 No DTI studies have been reported on effects of prenatal exposure to drugs of abuse other than alcohol.

The present study targets FA, DA, and DR of WM in children with prenatal polysubstance, predominantly opiate, exposure. To our knowledge, there are no previous studies in this area, so the present study is explorative and hypotheses are tentative. To the extent that such exposure disrupts myelination, we expected lower FA and higher DR in exposed children. Myelination begins prenatally9 and appears to progress in an orderly manner during infancy from inferior to superior, posterior to anterior, and central to peripheral regions.18 We, therefore, hypothesized that the largest effects of prenatal substance exposure would be found on relatively central, inferior, and posterior WM. Finally, on the basis of the important role of cerebral WM in cognitive function,15 we expected FA and DA to correlate positively and DR to correlate negatively with IQ and FFD as measured by the WISC-R.19

Materials and Methods

Sample

The present sample is drawn from a longitudinal project on the development of children born to mothers who abused drugs during pregnancy, further details of which are described elsewhere.3,4,8 The biologic mothers of the substance-exposed children were referred to the perinatal risk project because of concerns about substance abuse by medical or social staff at the municipal health service. Control children without known risk of biologic mothers with a history of alcohol or illicit drug abuse were recruited from local maternal and child health centers. Fourteen children prenatally exposed to drugs of abuse without a diagnosis of FASD and 14 controls were included in the present study. Sample characteristics are presented in Table 1.

View this table:
  • View inline
  • View popup
Table 1:

Sample characteristics of the 2 groups

One-way ANOVA showed significant group differences in several characteristics. Because the inclusion of 2 prematurely born children (see below) may have disproportionately increased group differences, analyses were also repeated without these children. All significant group differences remained. After exclusion, in the substance-exposed group, mean gestational age was 39.0 ± 1.3 weeks; birth weight, 3158 ± 595 g; birth length, 48.3 cm (SD, 2.6 cm); and head circumference, 34.5 ± 1.6 cm. The biologic mothers of 10 of the substance-exposed children reported opiates as their main drug of choice. Nine of these women reported use of a range of 1–5 other substances, including benzodiazepines, neuroleptics, cannabis, alcohol, cocaine, and amphetamine. Of the 4 mothers not reporting heroin use, 1 reported cocaine; 2, psychopharmacologic substances; and 1, alcohol as the main substance of choice, in addition to various other substances, including benzodiazepines, neuroleptics, amphetamine, and alcohol. Twelve of the substance-exposed children had neonatal abstinence syndrome20 symptoms, and 10 were medicated during the first 8 weeks after birth. All biologic mothers of the exposed group reported smoking tobacco during pregnancy. One control mother reported infrequent cigarette smoking. All substance-exposed children moved from their biologic mothers within 6 weeks after birth, were placed in permanent foster care within their first year of life, and were later adopted by the same foster parents.

Among the opiate-exposed children, 1 was born with a myelomeningocele. All brain scans were inspected by a neuroradiologist. They were examined for anatomic abnormalities, including congenital changes, and the neuroradiologist looked for signal-intensity differences/pathology in white and gray matter and examined CSF spaces. No signs of cerebral pathology were found. This was also the case with the scans of the child with myelomeningocele. There was no sign of intracerebral pathology, either hydrocephalus or any Chiari malformation. Another of the opiate-exposed children had been diagnosed with AS. We decided to include both children. Maternal opiate addiction may be associated with significant prenatal risk both because of direct teratogenic factors and poor health and dietary conditions. Myelomeningocele may be associated with inadequate maternal folic acid intake, low maternal vitamin B12 status, and exposure to some teratogens; and approximately 25% of the incidence of AS is associated with pre- or perinatal risk.21,22 Prenatal substance exposure is also associated with heightened risk of premature birth23 and ADHD.4 Two of the opiate-exposed children were born prematurely (gestational age < 37 weeks, namely 31 and 34 weeks), and 4 of the substance-exposed children in the present sample had an ADHD diagnosis, for which they were medicated. The study (including both substance-exposed and control children) was approved by the regional committee for medical research ethics for South Norway. All parents signed informed consent. The children were given adapted information (information in a simplified language), and all gave spoken consent.

As part of previous follow-ups, the sample has undergone behavioral assessments.2–4 For all except 1 child, the WISC-R19 was administered at a mean age of 8.63 ± 0.71 years. The WISC-R is a general ability measure comprising 12 subtests. Total IQ is calculated from all subtests, while the FFD factor is comprised of the Arithmetic, Digit Span, and Coding subtests. It has been suggested that this factor reflects resistance to the effects of distracting stimuli, and executive and short term memory processes involved in planning, monitoring and evaluating task performance.24

DTI Acquisition and Processing

A Sonata 1.5T MR imaging scanner (Siemens, Erlangen, Germany) with an 8-channel head coil was used. A single-shot echo-planar imaging−based 6-direction diffusion-weighted sequence was used with 40 axial sections (section thickness, 2.6 mm; FOV, 230 mm; in-plane pixel size, 1.7969 × 1.7969 mm; TR/TE/ flip angle, 6100 ms/85 ms/90°). Two-to-4 successive runs were used, with 1 non-diffusion-weighted (b = 0) image in addition to 6 diffusion-weighted images obtained per acquisition. The volumes were eddy current− and motion-corrected relative to the first b = 0 volume by using the Diffusion Toolbox of FMRIB, part of FMRIB Software Library (http://www.fmrib.ox.ac.uk/fsl/).25 To preserve the orientational information after motion correction, we reoriented the B matrix accordingly by applying the resulting rotations from the motion-correction procedure.26 The acquisitions were averaged before extracting nonbrain tissue (skull, CSF, etc) by using the Brain Extraction Tool.27 The Diffusion Toolbox of FMRIB was used to fit a diffusion tensor model to the data at each voxel. Voxelwise values of FA as well as DA (λ1) and DR ([λ2 + λ3] / 2) to the principal diffusion direction were calculated.

Statistical Analyses

Voxelwise statistical analysis of the FA data were carried out by using Tract-Based Spatial Statistics,28 part of the FMRIB Software Library.24 All subjects' FA data were aligned into a common space by using nonlinear registration.29–31 Every participant was registered to every other participant, and the most typical was chosen as the target (ie, the target image that minimized the amount of warping required for all other subjects to align to it).28 The mean FA image was created and thinned to create a mean FA skeleton representing the centers of all tracts common to the group. The skeleton was thresholded at FA > 0.25 and included 131,198 1-mm3 voxels. For a discussion of the choice of thresholding procedure, see the Appendix.

The tract invariant skeleton for each participant was used to model group effects in a GLM, with age and sex as covariates. Cluster-size thresholding was carried out on the resulting statistical maps by clustering contiguous voxels by means of 26-neighbor connectivity in the skeleton with a cluster-forming threshold of P < .05 for the 2 contrasts (Exposed > Controls, Controls > Exposed). Due to the small number of this rare sample, stringent permutation-based corrections were deemed too strict. Instead, to ensure stability of effects, we selected only clusters with ≥100 voxels for further analyses, and reliability within these were assessed by split-half analysis. The FA, DR, and DA values within identified clusters were subjected to the split-half analysis, where each sample was divided into halves matched with respect to age and sex, and analysis was run on the 2 subsamples. Furthermore, group differences in FA, DR, and DA values within identified clusters were also subjected to analysis with the substance-exposed sample limited to only children exposed to heroin and to only children exposed to heroin born at term and not having a diagnosis of myelomeningocele or AS. To explore the regional distribution of the effects from the whole brain analyses not restricted by the cluster size threshold of ≥100 voxels, we counted all voxels yielding a statistically significant (P < .05) group difference in FA within probabilistically defined fiber tracts.32–34 This method has previously been used in conjunction with and in addition to cluster-size inference.35

Results

Group Differences

A cluster-forming threshold of P < .05 identified 10 clusters of ≥100 voxels for the Controls > Exposed contrast and none for the Exposed > Controls contrast. The clusters are shown in Fig 1 and On-line Fig 1, and their size and Montreal Neurological Institute coordinates are listed in On-line Table 1. In general, clusters were found in relatively central, posterior, and inferior WM (see Table 2 for a short anatomic description). One exception was a right-sided cluster in an anterior part of the Fmin. Results for group differences in DA and DR, respectively, from a GLM with age and sex as covariates, are shown in Table 2, and group mean values are shown in Fig 2 . Differences in DR, more than DA, contributed to the lower FA in the substance-exposed children. In all cases of significant differences, DA was lower and DR was higher in exposed children. The group differences within these clusters were upheld when the sample groups were split in half (matched with respect to age and sex) and the analysis was rerun on the 2 subsamples. The results of the split half analysis are shown in On-line Table 2. For 7 of 10 clusters, the group effects were upheld at P < .05 in both halves of the sample, despite the substantial reduction in sample size. The 3 other clusters, I, H, and J, showed group effects at P < .05 in subsample A and around P ≤ .10 in subsample B in the split-half analysis. The group differences in FA, DR, and DA values within identified clusters were also subjected to reanalysis with the substance-exposed sample limited to only children either exposed to heroin or exposed to heroin, born at term, and not having a diagnosis of myelomeningocele or AS. In both cases, all group differences in FA and DR in the clusters remained significant (P < .05). The results of these analyses are shown in On-line Table 3.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Clusters of voxels (≥ 100) with significant (P < .05) group differences in FA are shown in red-yellow as they appear in the WM skeleton shown in green. For all clusters, FA was lower in the prenatally substance-exposed children.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Group mean values and standard errors of the mean in the 10 identified clusters for FA, DA, and DR in substance-exposed and control children.

View this table:
  • View inline
  • View popup
Table 2:

Results for group differences in FA, DA, and DR from a GLM analysis, with age and gender entered as covariates

Tract-wise percentages of voxels showing significant (P < .05) group differences in FA are shown in On-line Fig 2. Only the ILFR showed group differences in mean FA (F = 4.327, P = .048). A trend was also observed for the SLFL (F = 3.666, P = .068). However, it is evident that most tracts (8 of 9) showed a larger proportion of significant voxels in the Nonexposed > Exposed contrast than in the Exposed > Nonexposed contrast, as expected from the cluster size inference. These effects were distributed unevenly across tracts, suggesting some degree of anatomic specificity. The most affected tract was the ILF, followed by the SLF.

Correlations between Cognitive Variables and FA and Its Constituents

Five clusters correlated with cognitive function when the effects of age and sex were accounted for statistically: In the right deep temporal WM (cluster C), FA correlated positively with FFD (r = 0.42, P = .039) and DR correlated negatively with IQ (r = −0.46, P = .021) and FFD (r = −0.56, P = .004). The latter correlation was also seen with marginal significance for the opposite hemisphere counterpart (cluster B) of this cluster: r = 0.40, P = .051. DA in the superior division of the left lateral occipital area (cluster D) correlated positively with FFD (r = 0.44, P = .026). DR in the left inferior temporal gyrus (E) was negatively related to FFD (r = −0.40, P = .045), and FA in the right occipital/fusiform temporal gyrus (F) was positively related to IQ (r = 0. 44, P = .028). Finally, both FA and DR in the right prefrontal part of the Fmin (cluster J) correlated with IQ (r = 0.48, P = .016 and r = −0.49, P = .013 respectively). In a follow-up analysis, the observed significant correlations were rerun when the sample was split by group (Exposed versus Controls) to see whether these were primarily found in one group. This was not the case—with the exception of a negative correlation (r = −0.58, P = .048) between DR and IQ in the Fmin (cluster J) in the control group, the above correlations were nonsignificant (P < .05) within groups.

Discussion

This study showed differences in FA between children prenatally exposed to drugs of abuse, primarily opiates, and control children in regions of the WM of the brain. All identified clusters of differences showed lower FA in substance-exposed children. With the exception of a cluster in the Fmin, all effects were located in relatively central, posterior, and inferior parts of the brain. This is where myelination occurs relatively early in CNS development,18,36 and differences in these areas can be interpreted as corresponding to agents of early influence, though a number of potential confounds must also be considered. There were, to a somewhat greater extent, more group differences in DR than in DA across clusters. The exact neurobiologic principles governing radial and axial diffusivity are unknown, but DR has been related to the integrity and thickness of myelin sheets covering the axons,37,38 whereas DA may index axonal integrity.39

A recent autopsy study of adult opiate abusers did not find evidence for altered apoptotic pathways,40 but in keeping with histologic studies,11–13 opiate exposure may still alter fetal neuronal and glial development. One may thus speculate that substance exposure has a negative effect on myelin development, here reflected by increased radial diffusivity, though the exact molecular basis is unknown. Prenatal alcohol exposure may yield decreased expression of myelin basic protein41 and alter protein trafficking in astrocytes.42 Unfortunately, we were unable to find further studies that more specifically link ultrastructural changes in prenatal opiate and polysubstance exposure to the present DTI findings. The consequences of opiate use in pregnancy have not been well characterized, and animal models on fetal opiate exposure incorporating histologic, imaging, and behavioral observations would be most useful. Only a relatively low proportion of WM becomes myelinated in utero. No effects were observed in the early-myelinating brain stem, suggesting that there is not a straightforward correspondence between the timing of myelination, prenatal substance exposure, and later DTI effects. Additional factors governing localization of effect sites are unknown, but the regional distribution of different types of opiate receptors, for example, is known to vary,43 and this variation may be a possible source of influence. Some of the observed effects lie within areas known to myelinate prenatally (eg, the posterior limb of the internal capsule),44 whereas others are in areas where myelin is not yet seen at birth. However, both biochemical detection of myelin-associated lipids and proteins and increases in FA are known to precede the histologic detection of myelin.45,46 Hence, it is possible that mechanisms functioning before myelination could be affected by drug exposure in utero and ultimately affect the development of myelin.

Any neurobiologic inferences based on DTI-derived measures must be made with caution. FA is also influenced by crossing fibers and axon diameters, and increases in both can lead to increased DR, while potentially still being beneficial to cognitive function.47 The functional significance of the present findings can thus not be determined with certainty. Some of the presently identified clusters of group difference correlated with IQ and/or FFD in a predictable way in the total sample (ie, higher FA and DA correlated positively with cognitive performance and DR correlated negatively). The observed significant correlations in the total sample were, with the exception of a negative correlation between DR in a cluster in the Fmin and IQ in the control group, nonsignificant when the sample was split into controls and exposed children, suggesting that between-group differences, rather than individual differences within the group, drive these relationships. Sowell et al,10 on the other hand, reported that FA of the CC splenium correlated with visuomotor integration only in an FASD group and not in controls. Both measures and the nature of the exposure differed across these studies, so they cannot be directly compared. It is interesting, however, that the present group effects in deep temporal WM appear to correspond to 1 of the main sites of group difference identified in the study by Sowell et al. Sowell et al also found that gross structural WM volume was lower in some but not all regions in which FA was lower. Regional WM volume was not measured in the present study, but a previous report from the same sample showed generally smaller neuroanatomic volumes in the exposed children, including gross WM volume.8

The ILF and SLF showed the greatest proportion of voxels with lower FA in substance-exposed children. These are 2 of the most prominent association tracts bridging frontal, temporal, and parietal regions. In young healthy persons, FA in these tracts has previously been shown by Turken et al48 to correlate positively with scores on the Digit Symbol Substitution Test, which is also a part of WISC-R and the FFD score. The presently identified bilateral temporal effects in the ILF correspond to areas identified by Turken et al. They point out that these WM tracts support frontoposterior network interactions and that they are presumably critical for relaying the analysis of visual features to centers involved in control of visual scanning and response selection. The interaction of posterior association areas involved in perceptual representations and transformation and frontal areas involved in attentional control and regulation of actions may thus be compromised by prenatal drug exposure, with reduced myelination of these tracts.

The present study has a number of limitations. First and foremost, the exposure group studied is rare and, therefore, small. This feature warrants caution in judging the stability of the effects. However, the split-half analysis did support stability of the observed effects. All significant group differences were in the same (and predicted) direction. While specific mechanisms of action have been identified for different drugs, including opiates, there is also neuroimaging evidence to suggest that there may be some common mechanisms affected by prenatal exposure to different drugs.49 The specificity of effects of different drugs cannot be well assessed in this small study. However, for the entire observed group, differences in FA and DR remained significant when the substance-exposed sample was limited to the children exposed to heroin. Furthermore, all the observed group differences in FA and DR remained significant when the substance-exposed group was further reduced to the few children (n = 6) exposed to heroin and not born prematurely or having diagnosed AS or myelomeningocele.

Another limitation is that we cannot control for possible genetic differences between the groups studied, because differences in FA and FA-cognitive performance correlations may also be influenced by this.50,51 Other possible confounds include poor maternal nutrition and health. Furthermore and potentially related to all of the above, there is an increased incidence of other difficulties, including ADHD symptoms, in the substance-exposed group.3,8 All of these factors may affect both brain and cognition. Hence, we cannot attribute group differences among substance-exposed and control children and their correlation with cognitive function to the direct influence of substances on CNS development alone. This does not, however, make the observed differences and associations less important to further research.

Conclusions

The present study showed that in children prenatally exposed to drugs, primarily opiates, FA was lower and DR higher, relative to controls. These differences were mostly seen in relatively deep, central, and posterior parts of WM tracts and were moderately related to cognitive performance across groups. These are areas where myelination starts relatively early and, to some extent, prenatally. In correspondence with findings from histologic studies, opiate exposure in utero may have neurotoxic as well as gliotoxic effects on WM development. However, one cannot conclude with certainty, given potential confounding factors such as genetic differences and maternal nutrition and health. There is, therefore, a need to research effects of prenatal substance exposure in additional samples.

Footnotes

  • This work was support by the Norwegian Research Council and the Institute of Psychology at the University of Oslo.

  • Indicates article with supplemental on-line tables.

  • Indicates article with supplemental on-line figures.www.ajnr.org

Indicates open access to non-subscribers at www.ajnr.org

References

  1. 1.↵
    1. Suess PE,
    2. Newlin DB,
    3. Porges SW
    . Motivation, sustained attention, and autonomic regulation in school-age boys exposed in utero to opiates and alcohol. Exp Clin Psychopharmacol 1997;5:375–87
    CrossRefPubMed
  2. 2.↵
    1. Moe V,
    2. Slinning K
    . Prenatal drug exposure and the conceptualization of long-term effects. Scand J Psychol 2002;43:41–47
    CrossRefPubMed
  3. 3.↵
    1. Moe V
    . Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years. J Dev Behav Pediatr 2002;23:330–39
    PubMed
  4. 4.↵
    1. Slinning K
    . Foster placed children prenatally exposed to poly-substances: attention-related problems at ages 2 and 4 1/2. Eur Child Adolesc Psychiatry 2004;13:19–27
    CrossRefPubMed
  5. 5.↵
    1. Riley EP,
    2. McGee CL
    . Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp Biol Med (Maywood) 2005;230:357–65
    Abstract/FREE Full Text
  6. 6.↵
    1. Chang L,
    2. Smith LM,
    3. LoPresti C,
    4. et al
    . Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004;132:95–106
    CrossRefPubMed
  7. 7.↵
    1. Walhovd KB,
    2. Moe V,
    3. Slinning K,
    4. et al
    . Corrigendum to “volumetric cerebral characteristics of children exposed to opiates and other substances in utero.” [Neuroimage 2007;36:1331–44]. Neuroimage 2008;41:1514–16
    CrossRef
  8. 8.↵
    1. Walhovd KB,
    2. Moe V,
    3. Slinning K,
    4. et al
    . Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 2007;36:1331–44
    CrossRefPubMed
  9. 9.↵
    1. de Graaf-Peters VB,
    2. Hadders-Algra M
    . Ontogeny of the human central nervous system: what is happening when? Early Hum Dev 2006;82:257–66
    CrossRefPubMed
  10. 10.↵
    1. Sowell ER,
    2. Johnson A,
    3. Kan E,
    4. et al
    . Mapping white matter integrity and neurobehavioral correlates in children with fetal alcohol spectrum disorders. J Neurosci 2008;28:1313–19
    Abstract/FREE Full Text
  11. 11.↵
    1. Hu S,
    2. Sheng WS,
    3. Lokensgard JR,
    4. et al
    . Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 2002;42:829–36
    CrossRefPubMed
  12. 12.↵
    1. Knapp PE,
    2. Maderspach K,
    3. Hauser KF
    . Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses. Glia 1998;22:189–201
    CrossRefPubMed
  13. 13.↵
    1. Stiene-Martin A,
    2. Knapp PE,
    3. Martin K,
    4. et al
    . Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: impact on gliogenesis in vivo. Glia 2001;36:78–88
    CrossRefPubMed
  14. 14.↵
    1. Mori S,
    2. Zhang J
    . Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006;51:527–39
    CrossRefPubMed
  15. 15.↵
    1. Wozniak JR,
    2. Lim KO
    . Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev 2006;30:762–74
    CrossRefPubMed
  16. 16.↵
    1. Ma X,
    2. Coles CD,
    3. Lynch ME,
    4. et al
    . Evaluation of corpus callosum anisotropy in young adults with fetal alcohol syndrome according to diffusion tensor imaging. Alcohol Clin Exp Res 2005;29:1214–22
    CrossRefPubMed
  17. 17.↵
    1. Wozniak JR,
    2. Mueller BA,
    3. Chang PN,
    4. et al
    . Diffusion tensor imaging in children with fetal alcohol spectrum disorders. Alcohol Clin Exp Res 2006;30:1799–806
    CrossRefPubMed
  18. 18.↵
    1. Barkovich AJ,
    2. Kjos BO,
    3. Jackson DE Jr.,
    4. et al
    . Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 1988;166:173–80
    PubMed
  19. 19.↵
    1. Wechsler D
    . Wechsler Intelligence Scale for Children-Revised. New York: The Psychological Corporation; 1974
  20. 20.↵
    1. Finnegan LP,
    2. Kron RE,
    3. Connaughton JF,
    4. et al
    . Neonatal abstinence syndrome: assessment and management. Addict Dis 1975; 2: 141– 58
    PubMed
  21. 21.↵
    1. Gillberg C,
    2. Cederlund M
    . Asperger syndrome: familial and pre- and perinatal factors. J Autism Dev Disord 2005;35:159–66
    CrossRefPubMed
  22. 22.↵
    1. Mitchell LE,
    2. Adzick NS,
    3. Melchionne J,
    4. et al
    . Spina bifida. Lancet 2004;364:1885–95
    CrossRefPubMed
  23. 23.↵
    1. Bada HS,
    2. Das A,
    3. Bauer CR,
    4. et al
    . Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol 2005;25:631–37
    CrossRefPubMed
  24. 24.↵
    1. Wielkiewicz RM
    . Interpreting low scores on the WISC-R third factor: it's more than distractibility. Psychological Assessment: a Journal of Consulting and Clinical Psychology 1990;2:91–97
  25. 25.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW,
    4. et al
    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–19
    CrossRefPubMed
  26. 26.↵
    1. Leemans A,
    2. Jones DK
    . The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 2009;61:1336–49
    CrossRefPubMed
  27. 27.↵
    1. Smith SM
    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55
    CrossRefPubMed
  28. 28.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al
    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505
    CrossRefPubMed
  29. 29.↵
    1. Rueckert D,
    2. Sonoda LI,
    3. Hayes C,
    4. et al
    . Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 1999;18:712–21
    CrossRefPubMed
  30. 30.↵
    1. Andersson JLR,
    2. Jenkinson M,
    3. Smith S
    . Non-linear registration, aka spatial normalization. FMRIB technical report TR07JA2. 2007. http://www.fmrib.ox.ac.uk/fslanalysis/techrep/tr07ja2/tr07ja2.pdf. Accessed November 10, 2009
  31. 31.↵
    1. Andersson JLR,
    2. Jenkinson M,
    3. Smith S
    . Non-linar optimisation. FMRIB technical report TR07JA1. 2007. http://www.fmrib.ox.ac.uk/fslanalysis/techrep/tr07ja1/tr07ja1.pdf. Accessed November 10, 2009
  32. 32.↵
    1. Wakana S,
    2. Caprihan A,
    3. Panzenboeck MM,
    4. et al
    . Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 2007;36:630–44
    CrossRefPubMed
  33. 33.↵
    1. Mori S,
    2. Wakana S,
    3. Nagae-Poetscher LM
    et al. MRI Atlas of Human White Matter. Amsterdam, the Netherlands: Elsevier; 2005
  34. 34.↵
    1. Hua K,
    2. Zhang J,
    3. Wakana S,
    4. et al
    . Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage 2008; 39: 336– 47
    CrossRefPubMed
  35. 35.↵
    1. Westlye LT,
    2. Walhovd KB,
    3. Bjørnerud A,
    4. et al
    . Error related negativity is mediated by fractional anisotropy in the posterior cingulate gyrus: a study combining diffusion tensor imaging and electrophysiology in healthy adults. Cereb Cortex 2009;19:293–304. Epub 2008 May 22
    Abstract/FREE Full Text
  36. 36.↵
    1. Bendersky M,
    2. Musolino PL,
    3. Rugilo C,
    4. et al
    . Normal anatomy of the developing fetal brain: ex vivo anatomical-magnetic resonance imaging correlation. J Neurol Sci 2006;250:20–26
    CrossRefPubMed
  37. 37.↵
    1. Song SK,
    2. Sun SW,
    3. Ramsbottom MJ,
    4. et al.
    Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002; 17:1429–36
    CrossRefPubMed
  38. 38.↵
    1. Song SK,
    2. Yoshino J,
    3. Le TQ,
    4. et al
    . Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26:132–40
    CrossRefPubMed
  39. 39.↵
    1. Song SK,
    2. Sun SW,
    3. Ju WK,
    4. et al
    . Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20:1714–22
    CrossRefPubMed
  40. 40.↵
    1. Garcia-Fuster MJ,
    2. Ramos-Miguel A,
    3. Rivero G,
    4. et al
    . Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers. Neuroscience 2008;157:105–19. Epub 2008 Sep 9
    CrossRefPubMed
  41. 41.↵
    1. Bichenkov E,
    2. Ellingson JS
    . Ethanol exerts different effects on myelin basic protein and 2′, 3′-cyclic nucleotide 3′-phosphodiesterase expression in differentiating CG-4 oligodendrocytes. Brain Res Dev Brain Res 2001;128:9–16
    CrossRefPubMed
  42. 42.↵
    1. Guerri C,
    2. Pascual M,
    3. Renau-Piqueras J
    . Glia and fetal alcohol syndrome. Neurotoxicology 2001;22:593–99
    CrossRefPubMed
  43. 43.↵
    1. Chang KJ,
    2. Cooper BR,
    3. Hazum E,
    4. et al
    . Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol Pharmacol 1979;16:91–104
    Abstract/FREE Full Text
  44. 44.↵
    1. Kinney HC,
    2. Brody BA,
    3. Kloman AS,
    4. et al
    . Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol 1988;47:217–34
    CrossRefPubMed
  45. 45.↵
    1. Kinney HC,
    2. Karthigasan J,
    3. Borenshteyn NI,
    4. et al
    . Myelination in the developing human brain: biochemical correlates. Neurochem Res 1994;19:983–96
    CrossRefPubMed
  46. 46.↵
    1. Barkovich AJ
    . Concepts of myelin and myelination in neuroradiology. AJNR Am J Neuroradiol 2000;21:1099–109
    FREE Full Text
  47. 47.↵
    1. Tuch DS,
    2. Salat DH,
    3. Wisco JJ,
    4. et al
    . Choice reaction time performance correlates with diffusion anisotropy in white matter pathways supporting visuospatial attention. Proc Natl Acad Sci U S A 2005;102:12212–17
    Abstract/FREE Full Text
  48. 48.↵
    1. Turken A,
    2. Whitfield-Gabrieli S,
    3. Bammer R,
    4. et al
    . Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage 2008;42:1032–44
    CrossRefPubMed
  49. 49.↵
    1. Derauf C,
    2. Kekatpure M,
    3. Neyzi N,
    4. et al
    . Neuroimaging of children following prenatal drug exposure. Semin Cell Dev Biol 2009;20:441–54
    CrossRefPubMed
  50. 50.↵
    1. Chiang MC,
    2. Barysheva M,
    3. Shattuck DW,
    4. et al
    . Genetics of brain fiber architecture and intellectual performance. J Neurosci 2009;29:2212–24
    Abstract/FREE Full Text
  51. 51.↵
    1. Casey BJ,
    2. Epstein JN,
    3. Buhle J,
    4. et al
    . Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. Am J Psychiatry 2007;164:1729–36
    CrossRefPubMed
  • Received September 23, 2009.
  • Accepted after revision October 13, 2009.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 31 (5)
American Journal of Neuroradiology
Vol. 31, Issue 5
1 May 2010
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
White Matter Characteristics and Cognition in Prenatally Opiate- and Polysubstance-Exposed Children: A Diffusion Tensor Imaging Study
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
K.B. Walhovd, L.T. Westlye, V. Moe, K. Slinning, P. Due-Tønnessen, A. Bjørnerud, A. van der Kouwe, A.M. Dale, A.M. Fjell
White Matter Characteristics and Cognition in Prenatally Opiate- and Polysubstance-Exposed Children: A Diffusion Tensor Imaging Study
American Journal of Neuroradiology May 2010, 31 (5) 894-900; DOI: 10.3174/ajnr.A1957

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
White Matter Characteristics and Cognition in Prenatally Opiate- and Polysubstance-Exposed Children: A Diffusion Tensor Imaging Study
K.B. Walhovd, L.T. Westlye, V. Moe, K. Slinning, P. Due-Tønnessen, A. Bjørnerud, A. van der Kouwe, A.M. Dale, A.M. Fjell
American Journal of Neuroradiology May 2010, 31 (5) 894-900; DOI: 10.3174/ajnr.A1957
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Abbreviations
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • A Prospective Multi-Institutional Study Comparing the Brain Development in the Third Trimester between Opioid-Exposed and Nonexposed Fetuses Using Advanced Fetal MR Imaging Techniques
  • DTI of Opioid-Exposed Fetuses Using ComBat Harmonization: A Bi-Institutional Study
  • Consequences of Parental Opioid Exposure on Neurophysiology, Behavior, and Health in the Next Generations
  • White Matter Injury and Structural Anomalies in Infants with Prenatal Opioid Exposure
  • Multimodal imaging of the self-regulating developing brain
  • Crossref (65)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Multimodal imaging of the self-regulating developing brain
    Anders M. Fjell, Kristine Beate Walhovd, Timothy T. Brown, Joshua M. Kuperman, Yoonho Chung, Donald J. Hagler, Vijay Venkatraman, J. Cooper Roddey, Matthew Erhart, Connor McCabe, Natacha Akshoomoff, David G. Amaral, Cinnamon S. Bloss, Ondrej Libiger, Burcu F. Darst, Nicholas J. Schork, B. J. Casey, Linda Chang, Thomas M. Ernst, Jeffrey R. Gruen, Walter E. Kaufmann, Tal Kenet, Jean Frazier, Sarah S. Murray, Elizabeth R. Sowell, Peter van Zijl, Stewart Mostofsky, Terry L. Jernigan, Anders M. Dale, Terry L. Jernigan, Connor McCabe, Linda Chang, Natacha Akshoomoff, Erik Newman, Anders M. Dale, Thomas Ernst, Anders M. Dale, Peter Van Zijl, Joshua Kuperman, Sarah Murray, Cinnamon Bloss, Nicholas J. Schork, Mark Appelbaum, Anthony Gamst, Wesley Thompson, Hauke Bartsch, Terry L. Jernigan, Anders M. Dale, Natacha Akshoomoff, Linda Chang, Thomas Ernst, Brian Keating, David Amaral, Elizabeth Sowell, Walter Kaufmann, Peter Van Zijl, Stewart Mostofsky, B.J. Casey, Erika J. Ruberry, Alisa Powers, Bruce Rosen, Tal Kenet, Jean Frazier, David Kennedy, Jeffrey Gruen
    Proceedings of the National Academy of Sciences 2012 109 48
  • Unraveling the secrets of white matter – Bridging the gap between cellular, animal and human imaging studies
    K.B. Walhovd, H. Johansen-Berg, R.T. Káradóttir
    Neuroscience 2014 276
  • Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review
    Jennifer N. Lind, Julia D. Interrante, Elizabeth C. Ailes, Suzanne M. Gilboa, Sara Khan, Meghan T. Frey, April L. Dawson, Margaret A. Honein, Nicole F. Dowling, Hilda Razzaghi, Andreea A. Creanga, Cheryl S. Broussard
    Pediatrics 2017 139 6
  • Longitudinal cognitive development of children born to mothers with opioid and polysubstance use
    Egil Nygaard, Vibeke Moe, Kari Slinning, Kristine B. Walhovd
    Pediatric Research 2015 78 3
  • Neural Tract Development of Infants Born to Methadone-Maintained Mothers
    Kristine B. Walhovd, Richard Watts, Inge Amlien, Lianne J. Woodward
    Pediatric Neurology 2012 47 1
  • What Does Diffusion Tensor Imaging Reveal About the Brain and Cognition in Fetal Alcohol Spectrum Disorders?
    Jeffrey R. Wozniak, Ryan L. Muetzel
    Neuropsychology Review 2011 21 2
  • Brain morphology in school-aged children with prenatal opioid exposure: A structural MRI study
    Eivind Sirnes, Leif Oltedal, Hauke Bartsch, Geir Egil Eide, Irene B. Elgen, Stein Magnus Aukland
    Early Human Development 2017 106-107
  • Substance exposure in utero and developmental consequences in adolescence: A systematic review
    Tina Birk Irner
    Child Neuropsychology 2012 18 6
  • Fractional Anisotropy of the Fornix and Hippocampal Atrophy in Alzheimer’s Disease
    Kejal Kantarci
    Frontiers in Aging Neuroscience 2014 6
  • Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure
    Fair M. Vassoler, David J. Oliver, Cristina Wyse, Ashley Blau, Michael Shtutman, Jill R. Turner, Elizabeth M. Byrnes
    Neuropharmacology 2017 113

More in this TOC Section

  • SyMRI & MR Fingerprinting in Brainstem Myelination
  • Comparison of Image Quality and Radiation Dose in Pediatric Temporal Bone CT Using Photon-Counting Detector CT and Energy-Integrating Detector CT
  • Venous Sinus Stenosis in Mucopolysaccharidosis I
Show more Pediatrics

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • AJNR Awards
  • ASNR Foundation Special Collection
  • Most Impactful AJNR Articles
  • Photon-Counting CT
  • Spinal CSF Leak Articles (Jan 2020-June 2024)

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire